131 results

• Vision Problems From Ozempic, Other GLP-1 Drugs May Result From Rapid Correction of Hyperglycemia: Study

  February 6, 2025

  Irvin Jackson

  A new study raises questions about whether Ozempic vision loss is caused by toxic ingredients in the drug, or the body's reaction to quickly dropping blood sugar levels.

• GLP-1 Lawsuit Defendants Filed Motion To Dismiss Most Claims in Plaintiffs’ Master Complaint

  January 31, 2025

  Irvin Jackson

  Two major drug manufacturers are asking a federal judge to dismiss most claims presented in GLP-1 lawsuits, which allege that side effects of Ozempic, Mounjaro and similar drugs cause severe gastrointestinal side effects.

• Side Effects of Ozempic, Other GLP-1 Drugs Are Mixed, With Net Benefits Overall: Study

  January 22, 2025

  Irvin Jackson

  A new study attempts to categorize the benefits and risks of drugs like Ozempic and Mounjaro, finding that they decrease the risk of many metabolic health problems due to the weight lost, while warning of potential gastrointestinal problems such as stomach paralysis, and an increased risk of acute pancreatitis.

• Evidentiary Hearing for “Cross Cutting” Ozempic Lawsuit Causation Issues Scheduled for May 2025

  January 3, 2025

  Irvin Jackson

  A federal judge has scheduled a hearing in May to review evidence linking Ozempic and similar drugs to gastrointestinal problems, such as gastroparesis and intestinal obstruction.

• EU Launches Investigation Into Ozempic Vision Loss Problems

  December 23, 2024

  Irvin Jackson

  Following nearly 20 reports of vision problems from Ozempic or Wegovy since a study was published in July 2024, Danish health officials are calling for an EU investigation into the safety of semaglutide-based drugs.

• Ozempic NAION Vision Loss Risks Confirmed in Another Study

  December 16, 2024

  Irvin Jackson

  A Danish study warns that using Ozempic and Wegovy could double the risk of a condition known to cause vision changes and blindness.

• MDL Judge Schedules Ozempic Lawsuit Status Conferences Throughout 2025

  December 5, 2024

  Irvin Jackson

  With the first Ozempic lawsuit bellwether trials not expected to begin until at least late 2026 or early 2027, the court will address motions to dismiss and other “cross cutting” issues in 2025.

• Ozempic Ileus Lawsuit Filed by Woman Left With Gastrointestinal Problems After Receiving Injections for 2 Years

  November 25, 2024

  Irvin Jackson

  Alabama woman is seeking both compensatory and punitive damages, claiming she suffered multiple gastrointestinal problems due to the side effects of the Novo Nordisk diabetes drug, Ozempic.

• Ozempic Side Effects May Shrink Heart Muscles, Study Warns

  November 20, 2024

  Irvin Jackson

  Canadian researchers warn that side effects of Ozempic, Wegovy and other similar drugs may cause the heart muscles to atrophy, making it more difficult for users to exercise.

• Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL

  November 15, 2024

  Irvin Jackson

  Plaintiffs pursuing GLP-1 injury lawsuits have filed a Master Complaint outlining common allegations being pursued against Novo Nordisk and Eli Lilly over their diabetes and weight loss drugs, including Ozempic, Wegovy, Mounjaro and others.